Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Measles vaccine potency and Sero- conversion rates among infants receiving measles immunization in Ilorin, Kwara state, Nigeria.

This study was designed to assess the seroconversion rate of measles vaccine among infants receiving measles immunization in Ilorin, Nigeria. The pre- and post-measles vaccination sera of the children were tested using the Haemagglutination Inhibition test. The measles vaccines administered at the i...

Full description

Saved in:
Bibliographic Details
Format: Article
Published: 2014
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000njm a2000000a 4500
001 oai:repository.ui.edu.ng:123456789/12703
042 |a dc 
720 |a Fowotade, A.  |e author 
720 |a Okonko, I. O.  |e author 
720 |a Nwabuisi, C.  |e author 
720 |a Bakare, R. A.  |e author 
720 |a Fadeyi, A.  |e author 
720 |a Adu, F. D.  |e author 
260 |c 2014 
520 |a This study was designed to assess the seroconversion rate of measles vaccine among infants receiving measles immunization in Ilorin, Nigeria. The pre- and post-measles vaccination sera of the children were tested using the Haemagglutination Inhibition test. The measles vaccines administered at the immunization centre were also tested for their potency using in-vitro titration method. Only 286 (71.5%) of the vacinees returned to give post-vaccination samples. All the infants screened had low pre-vaccination measles antibody titers. Thirty one (8.0%) of the infants had measles prior to vaccination. The seroconversion pattern showed that 196 (68.6%) of the infants developed protective antibody titers. Low seroconversion rate reported in this study was due to low vaccine potency. The titers of vaccines with low potency ranged between log10−1.0–log10−2.25 TCID/per dose. This was beside other non specific antiviral substances exhibited virus neutralizing activity. Only 3 (50%) of the 6 vaccine vials tested had virus titers of log10−3.25 to log10−3.5, which fell above the cut-off point recommended by the World Health Organization for measles vaccines. The sero-conversion rate of 68.6% observed among vaccinees is far lower than the immunity level of 95% required stopping measles transmission in an endemic community. Failure of 31.4% of these infants to sero-convert post vaccination can be attributed partly to administration of sub-potent vaccines. There is need for improvement and maintenance of effective vaccine cold chain system in Nigeria. There is need also for periodic monitoring of post-vaccination antibody titers as well as vaccine potency status in order to ensure development of protective seroconversion rates. 
024 8 |a 1532-1819 
024 8 |a 1532-4230 
024 8 |a ui_art_fowotade_measles_2015 
024 8 |a Journal of Immunoassay and Immunochemistry, 36(2), pp. 195–209 
024 8 |a https://repository.ui.edu.ng/handle/123456789/12703 
653 |a measles vaccine 
653 |a sero-conversion 
653 |a developing countries 
653 |a potency 
653 |a infants 
653 |a immunization 
653 |a Nigeria 
245 0 0 |a Measles vaccine potency and Sero- conversion rates among infants receiving measles immunization in Ilorin, Kwara state, Nigeria.